Mapping Discovery Service News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Serimmune Launches COVID Antibody Epitope Mapping Service
Better understand the B-cell response to SARS-CoV-2 infection and vaccination with high-resolution antibody epitope mapping across the entire SARS-CoV-2 proteome
News provided by
Share this article
Share this article
GOLETA, Calif., March 11, 2021 /PRNewswire/ Serimmune Inc., a leader in understanding the functional antibody repertoire s role in human disease, today announced the launch of a COVID antibody epitope mapping discovery service.  This offering now provides academic and biopharma researchers with ready access to Serimmune s proprietary Serum Epitope Repertoire Analysis (SERA) technology.
Requiring only 100 ul of serum or plasma per sample, Serimmune analyzes each sample for IgG and/or IgM antibodies using its proprietary, 10 billion member, random, bacterial peptide display library.  In addition to providing a composite score of the antibody epitopes identified in each sample to those ....

Akiko Iwasaki , Noah Nasser , Epitope Mapping Discovery Service , Prnewswire Serimmune Inc , Developmental Biology At Yale School Of Medicine , Serum Epitope Repertoire Analysis , Developmental Biology , Yale School , Mapping Discovery Service , Illumina Ventures , நோவா நாசர் , வளர்ச்சி உயிரியல் இல் யேல் பள்ளி ஆஃப் மருந்து , வளர்ச்சி உயிரியல் , யேல் பள்ளி , விவரணையாக்கம் கண்டுபிடிப்பு சேவை , இல்லுமின முயற்சிகள் ,